Literature DB >> 1424986

A cDNA clone for a novel nuclear protein with DNA binding activity.

T Mattioni1, C R Hume, S Konigorski, P Hayes, Z Osterweil, J S Lee.   

Abstract

In an effort to identify trans-acting factors regulating specific genes, we cloned a novel human gene, DBP-5. The cDNA clone contains a predicted open reading frame coding for a potential 1,179 amino acid protein. The mRNA corresponding to DBP-5 is ubiquitously distributed, and the gene is phylogenetically conserved. Immunofluorescence analyses with several cell lines indicate that the protein is localized to the nucleus. Sequence analysis revealed unusual features of the predicted protein structure, including four completely conserved repeats. The phylogenetic conservation of DBP-5, the ubiquity of its expression, its nuclear localization, and its ability to bind DNA sequences, raise the possibility that DBP-5 may play a role in the organization of interphase chromatin and/or in transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424986     DOI: 10.1007/bf00360539

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  21 in total

1.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

3.  Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients.

Authors:  C R Hume; L A Shookster; N Collins; R O'Reilly; J S Lee
Journal:  Hum Immunol       Date:  1989-05       Impact factor: 2.850

4.  Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation.

Authors:  W Reith; E Barras; S Satola; M Kobr; D Reinhart; C H Sanchez; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 5.  Eukaryotic transcriptional regulatory proteins.

Authors:  P F Johnson; S L McKnight
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold.

Authors:  J Mirkovitch; M E Mirault; U K Laemmli
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

7.  Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant.

Authors:  P Gladstone; D Pious
Journal:  Somatic Cell Genet       Date:  1980-03

8.  Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors.

Authors:  C R Hume; J S Lee
Journal:  Hum Immunol       Date:  1989-12       Impact factor: 2.850

9.  Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element.

Authors:  H C Liou; M R Boothby; L H Glimcher
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

10.  A rapid single-stranded cloning strategy for producing a sequential series of overlapping clones for use in DNA sequencing: application to sequencing the corn mitochondrial 18 S rDNA.

Authors:  R M Dale; B A McClure; J P Houchins
Journal:  Plasmid       Date:  1985-01       Impact factor: 3.466

View more
  8 in total

Review 1.  The role of SON in splicing, development, and disease.

Authors:  Xinyi Lu; Huck-Hui Ng; Paula A Bubulya
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-04-30       Impact factor: 9.957

2.  SON controls cell-cycle progression by coordinated regulation of RNA splicing.

Authors:  Eun-Young Ahn; Russell C DeKelver; Miao-Chia Lo; Tuyet Ann Nguyen; Shinobu Matsuura; Anita Boyapati; Shatakshi Pandit; Xiang-Dong Fu; Dong-Er Zhang
Journal:  Mol Cell       Date:  2011-04-22       Impact factor: 17.970

3.  Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis.

Authors:  Eun-Young Ahn; Ming Yan; Oxana A Malakhova; Miao-Chia Lo; Anita Boyapati; Hans Beier Ommen; Robert Hines; Peter Hokland; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

4.  SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.

Authors:  Jung-Hyun Kim; Melody C Baddoo; Eun Young Park; Joshua K Stone; Hyeonsoo Park; Thomas W Butler; Gang Huang; Xiaomei Yan; Florencia Pauli-Behn; Richard M Myers; Ming Tan; Erik K Flemington; Ssang-Taek Lim; Eun-Young Erin Ahn
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

5.  De Novo Truncating Variants in SON Cause Intellectual Disability, Congenital Malformations, and Failure to Thrive.

Authors:  Mari J Tokita; Alicia A Braxton; Yunru Shao; Andrea M Lewis; Marie Vincent; Sébastien Küry; Thomas Besnard; Bertrand Isidor; Xénia Latypova; Stéphane Bézieau; Pengfei Liu; Connie S Motter; Catherine Ward Melver; Nathaniel H Robin; Elena M Infante; Marianne McGuire; Areeg El-Gharbawy; Rebecca O Littlejohn; Scott D McLean; Weimin Bi; Carlos A Bacino; Seema R Lalani; Daryl A Scott; Christine M Eng; Yaping Yang; Christian P Schaaf; Magdalena A Walkiewicz
Journal:  Am J Hum Genet       Date:  2016-08-18       Impact factor: 11.025

6.  SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.

Authors:  Lana Vukadin; Jung-Hyun Kim; Eun Young Park; Joshua K Stone; Nathan Ungerleider; Melody C Baddoo; Hyun Kyung Kong; Alexander Richard; Johnny Tran; Hannah Giannini; Erik K Flemington; Ssang-Taek Steve Lim; Eun-Young Erin Ahn
Journal:  Cancer Gene Ther       Date:  2020-11-27       Impact factor: 5.987

7.  Targeting of MAPK-associated molecules identifies SON as a prime target to attenuate the proliferation and tumorigenicity of pancreatic cancer cells.

Authors:  Toru Furukawa; Etsuko Tanji; Yuko Kuboki; Takashi Hatori; Masakazu Yamamoto; Kyoko Shimizu; Noriyuki Shibata; Keiko Shiratori
Journal:  Mol Cancer       Date:  2012-12-10       Impact factor: 27.401

8.  A novel frameshift variant in SON causes Zhu-Tokita-Takenouchi-Kim Syndrome.

Authors:  Ya Tan; Ling Duan; Kai Yang; Qian Liu; Jing Wang; Zhe Dong; Zhi Li; Yiwen He; Yousheng Yan; Li Lin
Journal:  J Clin Lab Anal       Date:  2020-04-14       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.